RE: RE: RE: Endo /BioDelivery Phase III (latest PR Good mention Nohandlezap. Yes, indeed, on top of everything else, those milestone payments by Endo ... which are near-term.
For those that are new to the BNC community, the agreement between Endo and Bioniche states,
Upon signing the Agreement, Bioniche received an up-front cash payment of US$20M. The Company also has the potential to receive a further US$110M in additional payments linked to the achievement of future clinical, regulatory and commercial milestones some of which are near-term. In addition to the above payments, Bioniche has retained exclusive product manufacturing rights and will receive a net-sales-related transfer price for supplying Endo with commercial product, following regulatory approval.
Kudo's to beech, sprules, diyodt, corpoate stooge and peasoupfog for providing some of the most intelligible commentary on this board ... these guys know what they are talking about.
Buy, hold and accumulate.